期刊
AMERICAN JOURNAL OF CARDIOLOGY
卷 88, 期 12, 页码 1403-+出版社
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/S0002-9149(01)02119-1
关键词
-
The direct thrombin inhibitor hirudin was associated with a reduced risk of nonfatal (re)infarction, a trend for a reduced risk of death or (re)infarction, and more frequent bleeding complications among 1,410 patients with acute coronary syndromes (ACS) who underwent early PCI in the GUSTO-IIb trial. Hirudin appears to enhance initial medical therapy for patients with ACS who undergo early percutaneous revascularization at the expense of an increased risk of bleeding.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据